BibTex RIS Cite

NİPAH VİRÜS SALGINLARI - NIPAH VIRUS OUTBREAK

Year 2019, Volume: 4 Issue: 3, 398 - 403, 18.10.2019

Abstract



Derlemenin amacı 2000 yıllarının başında henüz
yeni saptanmış bir virüs olan Nipah virüsünü tanımak ve günümüze kadar görülen
vaka artışlarını ortaya koymaktır. Fatalite hızı %100’lere kadar ulaşmakta olan
Nipah virüs salgınları başta Asya, Afrika ve Avustralya kıtasını olmak üzere
yakın temas ve kontamine yiyecekler ile kolaylıkla bulaşabildiğinden tüm
dünyada birçok insanı tehdit etmektedir. Bununla birlikte 15 Mayıs-25 Eylül
2019 tarihleri arasında salgın yapan hastalıklar, en son salgın yaptıkları coğrafik
bölge ve tarihleri tablo ile birlikte sunulmuştur.



References

  • 1. World Health Organization, Nipah Virus, 07 August 2018 [cited 2019 September 25]. Available from: https://www.who.int/csr/don/07-august-2018-nipah-virus-india/en/
  • 2. T.C. Sağlık Bakanlığı Seyahat Sağlığı Nipah Virus 2019 [cited 2019 September 25]. Available from: http://www.seyahatsagligi.gov.tr/Site/HastalikDetay/Nipah-Virusu
  • 3. Centers for Disease Control and Prevention Nipah Virus 2019 [cited 2019 September 25]. Available from: https://www.cdc.gov/vhf/nipah/index.html
  • 4. Drexler JF, Corman VM, Müller MA, Maganga GD, Vallo P, Binger T, et al. Bats host major mammalian paramyxoviruses. Nature communications. 2012;3:796.
  • 5. Kessler MK, Becker DJ, Peel AJ, Justice NV, Lunn T, Crowley DE, et al. Changing resource landscapes and spillover of henipaviruses. Annals of the New York Academy of Sciences. 2018;1429(1):78-99.
  • 6. Plowright RK, Becker DJ, Crowley DE, Washburne AD, Huang T, Nameer P, et al. Prioritizing surveillance of Nipah virus in India. PLOS Neglected Tropical Diseases. 2019;13(6):e0007393.
  • 7. Chua KB. Risk factors, prevention and communication strategy during Nipah virus outbreak in Malaysia. The Malaysian journal of pathology. 2010;32(2):75-80.
  • 8. Yu J, Lv X, Yang Z, Gao S, Li C, Cai Y, et al. The main risk factors of Nipah disease and its risk analysis in China. Viruses. 2018;10(10):572.
  • 9. Yadav PD, Shete AM, Kumar GA, Sarkale P, Sahay RR, Radhakrishnan C, et al. Nipah Virus Sequences from Humans and Bats during Nipah Outbreak, Kerala, India, 2018. Emerging infectious diseases. 2019;25(5):1003.
  • 10. Banerjee S, Niyas VKM, Soneja M, Shibeesh AP, Basheer M, Sadanandan R, et al. First experience of ribavirin postexposure prophylaxis for Nipah virus, tried during the 2018 outbreak in Kerala, India. Journal of Infection. 2019;78(6):491-503.
  • 11. Freiberg AN, Worthy MN, Lee B, Holbrook MR. Combined chloroquine and ribavirin treatment does not prevent death in a hamster model of Nipah and Hendra virus infection. The Journal of general virology. 2010;91(Pt 3):765.
  • 12. Snell N. Ribavirin therapy for Nipah virus infection. Journal of virology. 2004;78(18):10211-.
  • 13. Lo MK, Feldmann F, Gary JM, Jordan R, Bannister R, Cronin J, et al. Remdesivir (GS-5734) protects African green monkeys from Nipah virus challenge. Science translational medicine. 2019;11(494):eaau9242.
  • 14. Mire CE, Geisbert JB, Agans KN, Versteeg KM, Deer DJ, Satterfield BA, et al. Use of Single-Injection Recombinant Vesicular Stomatitis Virus Vaccine to Protect Nonhuman Primates Against Lethal Nipah Virus Disease. Emerging infectious diseases. 2019;25(6):1144.
  • 15. van Doremalen N, Lambe T, Sebastian S, Bushmaker T, Fischer R, Feldmann F, et al. A single-dose ChAdOx1-vectored vaccine provides complete protection against Nipah Bangladesh and Malaysia in Syrian golden hamsters. PLoS neglected tropical diseases. 2019;13(6):e0007462.
  • 16. World Health Organization Disease Outbreak News 2019 [cited 2019 September 25]. Available from: https://www.who.int/csr/don/archive/year/2019/en/

NIPAH VIRUS OUTBREAK

Year 2019, Volume: 4 Issue: 3, 398 - 403, 18.10.2019

Abstract



The aim of
this review is to learn about Nipah, a new identified virus at the beginning of
2000, and to present the cases increase up to date. The outbreaks of Nipah
virus, which has a fatality rate up to 100%, threaten many people all over the
world especially in Asia, Africa and Australia as it can easily be transmitted
by close contact and contaminated food.
Disease outbreaks
from May 15 to September 25 2019 are also presented with the latest geographic
region and date. 



References

  • 1. World Health Organization, Nipah Virus, 07 August 2018 [cited 2019 September 25]. Available from: https://www.who.int/csr/don/07-august-2018-nipah-virus-india/en/
  • 2. T.C. Sağlık Bakanlığı Seyahat Sağlığı Nipah Virus 2019 [cited 2019 September 25]. Available from: http://www.seyahatsagligi.gov.tr/Site/HastalikDetay/Nipah-Virusu
  • 3. Centers for Disease Control and Prevention Nipah Virus 2019 [cited 2019 September 25]. Available from: https://www.cdc.gov/vhf/nipah/index.html
  • 4. Drexler JF, Corman VM, Müller MA, Maganga GD, Vallo P, Binger T, et al. Bats host major mammalian paramyxoviruses. Nature communications. 2012;3:796.
  • 5. Kessler MK, Becker DJ, Peel AJ, Justice NV, Lunn T, Crowley DE, et al. Changing resource landscapes and spillover of henipaviruses. Annals of the New York Academy of Sciences. 2018;1429(1):78-99.
  • 6. Plowright RK, Becker DJ, Crowley DE, Washburne AD, Huang T, Nameer P, et al. Prioritizing surveillance of Nipah virus in India. PLOS Neglected Tropical Diseases. 2019;13(6):e0007393.
  • 7. Chua KB. Risk factors, prevention and communication strategy during Nipah virus outbreak in Malaysia. The Malaysian journal of pathology. 2010;32(2):75-80.
  • 8. Yu J, Lv X, Yang Z, Gao S, Li C, Cai Y, et al. The main risk factors of Nipah disease and its risk analysis in China. Viruses. 2018;10(10):572.
  • 9. Yadav PD, Shete AM, Kumar GA, Sarkale P, Sahay RR, Radhakrishnan C, et al. Nipah Virus Sequences from Humans and Bats during Nipah Outbreak, Kerala, India, 2018. Emerging infectious diseases. 2019;25(5):1003.
  • 10. Banerjee S, Niyas VKM, Soneja M, Shibeesh AP, Basheer M, Sadanandan R, et al. First experience of ribavirin postexposure prophylaxis for Nipah virus, tried during the 2018 outbreak in Kerala, India. Journal of Infection. 2019;78(6):491-503.
  • 11. Freiberg AN, Worthy MN, Lee B, Holbrook MR. Combined chloroquine and ribavirin treatment does not prevent death in a hamster model of Nipah and Hendra virus infection. The Journal of general virology. 2010;91(Pt 3):765.
  • 12. Snell N. Ribavirin therapy for Nipah virus infection. Journal of virology. 2004;78(18):10211-.
  • 13. Lo MK, Feldmann F, Gary JM, Jordan R, Bannister R, Cronin J, et al. Remdesivir (GS-5734) protects African green monkeys from Nipah virus challenge. Science translational medicine. 2019;11(494):eaau9242.
  • 14. Mire CE, Geisbert JB, Agans KN, Versteeg KM, Deer DJ, Satterfield BA, et al. Use of Single-Injection Recombinant Vesicular Stomatitis Virus Vaccine to Protect Nonhuman Primates Against Lethal Nipah Virus Disease. Emerging infectious diseases. 2019;25(6):1144.
  • 15. van Doremalen N, Lambe T, Sebastian S, Bushmaker T, Fischer R, Feldmann F, et al. A single-dose ChAdOx1-vectored vaccine provides complete protection against Nipah Bangladesh and Malaysia in Syrian golden hamsters. PLoS neglected tropical diseases. 2019;13(6):e0007462.
  • 16. World Health Organization Disease Outbreak News 2019 [cited 2019 September 25]. Available from: https://www.who.int/csr/don/archive/year/2019/en/
There are 16 citations in total.

Details

Primary Language Turkish
Subjects Clinical Sciences
Journal Section Miscellaneous
Authors

Feyza Nehir Muz 0000-0001-8747-9867

Publication Date October 18, 2019
Submission Date September 30, 2019
Published in Issue Year 2019 Volume: 4 Issue: 3

Cite

Vancouver Muz FN. NİPAH VİRÜS SALGINLARI - NIPAH VIRUS OUTBREAK. ESTUDAM Public Health Journal. 2019;4(3):398-403.

International Peer Reviewed Journal

Crossref Content Registration logo


The journal adopts Open Access Policy and does not request article proccessing charge (APC), article publishing charge or any other charges.

by-nc.eu.png
This work is licensed under a Creative Commons Attribution 4.0 License